Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases.
Founded in 2015, Holmusk is headquartered in Singapore and New York City with offices in Basel, London, Malaysia, Shanghai, and Durham (North Carolina). Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort.
Holmusk's vision is to build the world's largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.
Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.
Founded in 2015, Holmusk is headquartered in Singapore and New York City with offices in Basel, London, Malaysia, Shanghai, and Durham (North Carolina). Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort.
Holmusk's vision is to build the world's largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.
Holmusk’s proprietary technology is harnessed to analyze real-world data and drive data-driven medicine.
Employees: 51-200
Total raised: $31.25M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Health Cat... | healthcata... |
| - | Optum Vent... | optumventu... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.05.2020 | Series A | $21.5M | - |
| 25.09.2018 | Series A | $9.75M | - |
Mentions in press and media 30
| Date | Title | Description |
| 01.11.2024 | NeuroBlu: New Data Partner and Enterprise SSO Integration | Major expansion of behavioral health data with 940K+ new patient records, enterprise SSO integration, and enhanced analytics tools for deeper research insights. NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Holmusk, a global leader in behavioral h... |
| 25.01.2024 | Key Trends from the 2024 J.P. Morgan Healthcare Conference | Beneath the Californian sunshine (and a few showers) at JP Morgan, a revolution simmers. Not a political one, but a healthcare revolution propelled by necessity and fueled by innovation. Imagine a future where groundbreaking therapies reach... |
| 09.11.2023 | Holmusk Appoints Eze Abosi as Chief Growth Officer | New CGO joins Holmusk during a period of strong and sustainable growth for both the life science and payer/provider businesses. NEW YORK, Nov. 9, 2023 /PRNewswire/ -- Holmusk, a leading global behavioral health real-world evidence company, ... |
| 15.08.2023 | Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor | Kennedy to champion development of measurement standards to improve behavioral health care NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Holmusk, a leading global behavioral health real-world evidence company, today announced that former U.S. Rep... |
| 29.06.2023 | Roundups: 22 Recent Strategic Digital Health Partnerships | Advantus Health Partners forms a new 10-year, $2.9B strategic partnership with Medline to establish agility and scale, supply chain resiliency and enhanced clinical integration with the nurses and physicians who use Medline’s product. This ... |
| 22.06.2023 | Holmusk and Streamline Healthcare Solutions Announce Strategic Partnership To Bring Behavioral Health Predictive Analytics Tool to US Market | Initial phase will bring MaST, Holmusk's tool to help healthcare professionals better prioritize and manage behavioral health caseloads, to Mental Health Partners in Colorado NEW YORK, June 22, 2023 /PRNewswire/ -- Holmusk, a leading global... |
| 28.03.2023 | New Study Reveals Clinical Instability Predicts Psychiatric Hospitalization | First study of its kind, based on real-world data from Holmusk's NeuroBlu Database, shows patients who score highest for severity and instability were 45% more likely to be hospitalized NEW YORK, March 28, 2023 /PRNewswire/ -- For patients ... |
| 26.04.2022 | Holmusk Announces Publication of Seminal Paper on Real-World Evidence (RWE) Platform NeuroBlu | NEW YORK, April 26, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, is pleased to share with the scientific com... |
| 01.02.2022 | Holmusk Enters into Collaboration with Metrocare Services | NEW YORK, Feb. 1, 2022 /PRNewswire/ -- Holmusk, a leading global data science and health technology company building the world's largest real-world evidence (RWE) platform for behavioral health, has signed an agreement with Metrocare Servic... |
| 06.12.2021 | Holmusk Announces Closing of Strategic Investment from Healthcare and Life Science Industry Leaders | NEW YORK, Dec. 6, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the world's largest Real-World Evidence (RWE) platform for behavioral health, today announced the closing of a strategic inves... |
Show more